George Georgiou - Curriculum Vitae#

• Ph. D. Chemical Engineering, Cornell University, 1987
  
• M.S. Chemical Engineering, Cornell University, 1983
  
• B.Sc. Chemical Engineering, University of Manchester, U.K., 1981

• William H. Walker Award for Excellence in Contributions to Chemical Engineering Literature (AIChE), 2019
  
• Elected to National Academy of Inventors (NAI), 2015
  
• Elected to American Academy of Arts and Sciences (AAAS), 2015
  
• Named as one of “Top 20 Translational Researchers,” Nature Biotechnology, 2014
  
• Elected to National Academy of Medicine (NAM), 2011
  
• Named as one of “100 Eminent Chemical Engineers of the Modern Era,” American Institute of Chemical Engineering (AIChE), 2008
  
• Jay Bailey Award, Society of Biological Engineers, 2007
  
• AMGEN Award in Biochemical Engineering, 2007
  
• Food, Pharmaceutical and Bioengineering Award, American Institute of Chemical Engineering (AIChE), 2005
  
• Elected to National Academy of Engineering (NAE), 2005
  
• Fellow, American Academy of Microbiology, 2004
  
• Professional Progress Award for Outstanding Progress in Chemical Engineering, AIChE, 2003
  
• Marvin J. Johnson Award in Microbial and Biochemical Technology, American Chemical Society (ACS), 2003
  
• E. Bergman Award, US-Israel Science Foundation, 1995
  
• Presidential Young Investigator Award, US National Science Foundation, 1987

• D.I.C. Wang Frontiers in Biotechnology Lecture, Dept of Chemical Eng., MIT, Boston (2022)
  
• Kewaunee Distinguished Lecture, Dept. of Biomedical Eng., Duke U., Chapel Hill, NC (2018)
  
• KAIST Global Distinguished Lecturer, Dept. of Chemical Eng. KAIST, Taejon, S. Korea (2017)
  
• Grand Rounds Lecturer in Pediatric Oncology, Memorial Sloan Kettering, NY, NY (2014)
  
• Founders Lecture, Dept of Chemical Eng. U. Wisconsin, Madison, WI (2012)
  
• Exceptional Lectureship in Microbiology, Institute Pasteur, Paris France (2010)
  
• Dean’s Distinguished Lecture, Fu School of Engineering, Columbia U., New York NY (2010)
  
• Holtz Lecture, Dept of Chemical Eng., Johns Hopkins U., Baltimore MD (2009)
  
• Smith Lecture, Dept of Chemical Eng. Cornell U. Ithaca, NY (2005)
  
• Bayer Lecture, Dept. of Chemical Engineering, U.C. Berkeley, CA (2000)
  
• Vaughan Lecture, Dept. of Chemistry & Chemical Engineering, Caltech, Pasadena (1999)

• Founder and sole owner: GGMJ LLC; acquired by Maxygen (NSDQ: Maxy) (2000)
  
• Founder, Board of Directors (2013-18), Aeglea Biotherapeutics (NSDQ: AGLE), Austin TX
  
• Founder, Board of Directors (2016-20), Ikena Oncology (NSDQ: IKNA now IMA), Boston MA
  
• SAB, Pfizer Global Biologic Technologies (2015-2021)
  
• SAB, GigaGen (2019-21; acquired by Grifols in 2021)
  
• SAB, AMGEN (2023-Present)
  
• Founder and Director Fy Cappa Basel, Basel Switzerland (2024)
  
• 73 issued and 94 pending US patents